The Italian Network for Tumor Biotherapy (NIBIT): Getting together to push the field forward

Michele Maio, Hugues J M Nicolay, Paolo Ascierto, Filippo Belardelli, Roberto Camerini, Mario P. Colombo, Paola Queirolo, Ruggero Ridolfi, Vincenzo Russo, Lucia Anzalone, Ester Fonsatti, Giorgio Parmiani

Research output: Contribution to journalArticle

Abstract

As for a consolidated tradition, the 5th annual meeting of the Italian Network for Cancer Biotherapy took place in the Certosa of Pontignano, a Tuscan monastery, on September 20-22, 2007. The congress gathered more than 40 Italian leading groups representing academia, biotechnology and pharmaceutical industry. Aim of the meeting was to share new advances in cancer bio-immunotherapy and to promote their swift translation from pre-clinical research to clinical applications. Several topics were covered including: a) molecular and cellular mechanisms of tumor escape; b) therapeutic antibodies and recombinant constructs; c) clinical trials up-date and new programs; d) National Cooperative Networks and their potential interactions; e) old and new times in cancer immunology, an "amarcord". Here, we report the main issues discussed during the meeting.

Original languageEnglish
Article number8
JournalJournal of Translational Medicine
Volume6
DOIs
Publication statusPublished - Feb 12 2008

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Fingerprint Dive into the research topics of 'The Italian Network for Tumor Biotherapy (NIBIT): Getting together to push the field forward'. Together they form a unique fingerprint.

  • Cite this